Study of upper gastrointestinal endoscopic biopsies risk in patient on antithrombotic therapy

Study of upper gastrointestinal endoscopic biopsies risk in patient on antithrombotic therapy - Study of upper gastrointestinal endoscopic biopsies risk in patient on antithrombotic therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013520

Enrollment

200

Registered

2014-03-28

Start date

2012-12-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lesions that performed upper gastrointestinal endoscopic biopsy.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are performed gastrointestinal endoscopic biopsy under anti-thrombotic agents administration. For comparison, patients who are matdhed sex and age(within 5 years up and down) , without management of anti-thrombotic drugs are performed gastrointestinal endoscopic biopsy.

Exclusion criteria

Exclusion criteria: Emergency endoscopy cases.

Design outcomes

Primary

Measure	Time frame
The bleeding risk of upper gastrointestinal endoscopic biopsy in antithrombotic agent under continuation.	—

Countries

Japan

Contacts

Public ContactTakafumi Yuki

Shimane University Hospital Division of Gastrointestinal Endoscopy

yukitaka@med.shimane-u.ac.jp0853-20-2190

Outcome results